Published in Eur J Biochem on August 01, 1968
On the use of ultraviolet light to study protein-DNA crosslinking. Nucleic Acids Res (1976) 0.75
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell (1990) 3.98
Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science (1995) 2.83
A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature (1987) 2.60
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res (1998) 2.00
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. Oncogene (1994) 1.87
One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol Cell Biol (1987) 1.66
Immunological studies on viral polypeptide synthesis in cells replicating murine sarcoma-leukemia virus. J Virol (1972) 1.44
Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene (1996) 1.39
Morphometric analysis of AgNORs in uveal malignant melanoma. Anal Quant Cytol Histol (1998) 1.39
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab (1999) 1.37
Enzyme-linked immunosorbent assay for detection of T-2 toxin. Hoppe Seylers Z Physiol Chem (1982) 1.33
Evidence that a salt bridge in the light chain contributes to the physical stability difference between heavy and light human ferritins. J Biol Chem (1992) 1.30
Virus-specific messenger RNA and nascent polypeptides in polyribosomes of cells replicating murine sarcoma-leukemia viruses. Proc Natl Acad Sci U S A (1973) 1.30
Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus. Cancer Res (1985) 1.27
MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer. Mol Med (2001) 1.25
Block in the expression of differentiation markers of rat thyroid epithelial cells by transformation with Kirsten murine sarcoma virus. Cancer Res (1982) 1.25
A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts. Cell Death Differ (2011) 1.19
The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line. Cell Growth Differ (1993) 1.17
PATZ1 gene has a critical role in the spermatogenesis and testicular tumours. J Pathol (2008) 1.17
A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern. J Virol (1985) 1.14
Recurrent varicose veins of the lower limbs after surgery. Role of surgical technique (stripping vs. CHIVA) and surgeon's experience. G Chir (2012) 1.13
Transformation of thyroid epithelium is associated with loss of c-kit receptor. Cancer Res (1995) 1.13
The predicted DBL oncogene product defines a distinct class of transforming proteins. Proc Natl Acad Sci U S A (1988) 1.12
Refined localization to contiguous regions on chromosome 10q of the two genes (H4 and RET) that form the oncogenic sequence PTC. Oncogene (1991) 1.07
The oncogene associated with human papillary thyroid carcinoma (PTC) is assigned to chromosome 10 q11-q12 in the same region as multiple endocrine neoplasia type 2A (MEN2A). Oncogene (1989) 1.07
Metacognition as a mediator of the effects of impairments in neurocognition on social function in schizophrenia spectrum disorders. Acta Psychiatr Scand (2010) 1.06
galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas. Int J Cancer (1999) 1.06
Dissociation between transformed and differentiated phenotype in rat thyroid epithelial cells after transformation with a temperature-sensitive mutant of the Kirsten murine sarcoma virus. Mol Cell Biol (1983) 1.06
Acaricidal properties of the essential oil of Melaleuca alternifolia Cheel (tea tree oil) against nymphs of Ixodes ricinus. Vet Parasitol (2005) 1.03
Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1. Oncogene (1997) 1.01
Transformation of rat thyroid epithelial cells by Kirsten murine sarcoma virus. Int J Cancer (1981) 1.01
Circular dichroism study on the conformational stability of the dimerization domain of transcription factor LFB1. Biochemistry (1991) 1.01
Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage. Oncogene (2007) 1.00
Sequential reactivity of tyrosyl residues of thyroglobulin upon iodination catalyzed by thyroid peroxidase. J Biol Chem (1977) 1.00
Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B. Cancer Res (2001) 1.00
Preferential syntheisi of thyroxine from early iodinated tyrosyl residues in thyroglobulin. J Biol Chem (1974) 1.00
Outpatient inguinal hernia repair under local anaesthesia: feasibility and efficacy of ultrasound-guided transversus abdominis plane block. Hernia (2012) 1.00
Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues. Int J Cancer (1996) 0.99
Antifungal activity of Lavandula angustifolia essential oil against Candida albicans yeast and mycelial form. Med Mycol (2005) 0.98
Thyroglobulin interactions with thyroid plasma membranes. The existence of specific receptors and their potential role. J Biol Chem (1979) 0.97
Modifications occur at different structural levels during the heat denaturation of beta-lactoglobulin. Eur J Biochem (1996) 0.97
Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogonia. Int J Oncol (2000) 0.97
Changes in myocardial cytoskeletal intermediate filaments and myocyte contractile dysfunction in dilated cardiomyopathy: an in vivo study in humans. Heart (2000) 0.96
In vivo assessment of CdSe-ZnS quantum dots: coating dependent bioaccumulation and genotoxicity. Nanoscale (2012) 0.96
Induction of the c-fos oncogene by thyrotropic hormone in rat thyroid cells in culture. Science (1986) 0.95
The effect of environment on cystine disruption by ultraviolet light. Photochem Photobiol (1967) 0.95
Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior? Int J Immunopathol Pharmacol (2006) 0.95
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. Cancer Res (1997) 0.94
Gene rearrangement and Chernobyl related thyroid cancers. Br J Cancer (2000) 0.94
A review of bovine urothelial tumours and tumour-like lesions of the urinary bladder. J Comp Pathol (2009) 0.94
Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol (2001) 0.93
Local anaesthetic activity of the essential oil of Lavandula angustifolia. Planta Med (1999) 0.93
Reconstituted high-density lipoproteins with a disulfide-linked apolipoprotein A-I dimer: evidence for restricted particle size heterogeneity. Biochemistry (1997) 0.93
Signaling through Ras is essential for ret oncogene-induced cell differentiation in PC12 cells. J Biol Chem (2000) 0.93
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells. Proc Natl Acad Sci U S A (1996) 0.93
The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane. Oncogene (2001) 0.92
Molecular characterization of native and recombinant apolipoprotein A-IMilano dimer. The introduction of an interchain disulfide bridge remarkably alters the physicochemical properties of apolipoprotein A-I. J Biol Chem (1994) 0.92
Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo. Oncogene (1994) 0.92
Comparative study of the arterial and lacunary systems of the ventricular myocardium of elasmobranch and teleost fishes. Am J Anat (1983) 0.92
Microorganisms and biomolecules in space environment experiment ES 029 on Spacelab-1. Adv Space Res (1984) 0.91
Apolipoprotein AIMilano. Accelerated binding and dissociation from lipids of a human apolipoprotein variant. J Biol Chem (1985) 0.91
In vivo and in vitro growth-inhibitory effect of bovine seminal ribonuclease on a system of rat thyroid epithelial transformed cells and tumors. Cancer Res (1992) 0.90
Ret-mediated mitogenesis requires Src kinase activity. Cancer Res (1999) 0.90
Life sciences: microorganisms in the space environment. Science (1984) 0.89
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease. Endocrinology (1998) 0.89
Chromatin assembly factor-1 (CAF-1)-mediated regulation of cell proliferation and DNA repair: a link with the biological behaviour of squamous cell carcinoma of the tongue? Histopathology (2007) 0.89
Thyrotropin receptor gene expression in oncogene-transfected rat thyroid cells: correlation between transformation, loss of thyrotropin-dependent growth, and loss of thyrotropin receptor gene expression. Biochem Biophys Res Commun (1990) 0.89
Physical assessment of toxicology at nanoscale: nano dose-metrics and toxicity factor. Nanoscale (2011) 0.88
Isolation and characterization of the novel polyadenylate- and polyuridylate-degrading acid endoribonuclease V from calf thymus. J Biol Chem (1980) 0.88
Ligand stimulation of a Ret chimeric receptor carrying the activating mutation responsible for the multiple endocrine neoplasia type 2B. J Biol Chem (1996) 0.88
Identification of hormonogenic tyrosines in fragment 1218-1591 of bovine thyroglobulin by mass spectrometry. Hormonogenic acceptor TYR-12donor TYR-1375. J Biol Chem (1997) 0.88
Seminal ribonuclease inhibits tumor growth and reduces the metastatic potential of Lewis lung carcinoma. Cancer Res (1994) 0.88
Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure. Eur J Heart Fail (2004) 0.88
UV-induced cross-linking of proteins to plasmid pBR322 containing 8-azidoadenine 2'-deoxyribonucleotides. FEBS Lett (1988) 0.87
Thyroglobulin interactions with thyroid membranes. Relationship between receptor recognition of N-acetylglucosamine residues and the iodine content of thyroglobulin preparations. J Biol Chem (1981) 0.87
The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin. Hum Pathol (1996) 0.87
Isolation and characterization of discrete fragments of 27 S thyroid iodoprotein. Arch Biochem Biophys (1972) 0.87
Extreme dryness and DNA-protein cross-links. Adv Space Res (1992) 0.87
Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells. Oncol Res (1999) 0.87
Expression of proto-oncogene c-kit in high risk prostate cancer. Eur J Surg Oncol (2004) 0.87
The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. Oncogene (2001) 0.86
A new mechanism for the reabsorption of thyroid iodoproteins: selective fluid pinocytosis. Eur J Biochem (1982) 0.86
The Kirsten murine sarcoma virus induces rat thyroid carcinomas in vivo. Oncogene (1989) 0.86
Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene. Oncogene (1996) 0.86
Peptides and amino acids in the primordial hydrosphere. Biosystems (1975) 0.85
Molecular defects in thyroid carcinomas: role of the RET oncogene in thyroid neoplastic transformation. Eur J Endocrinol (1995) 0.85
Biosynthesis of thyroglobulin in vivo: formation and polymerization of subunits in the rat and guinea pig. Biochem Biophys Res Commun (1966) 0.85
CD and small-angle x-ray scattering of silk fibroin in solution. Biopolymers (1989) 0.85
The harderian gland in autoimmune diabetes of the nonobese diabetic mouse. Microsc Res Tech (1996) 0.85
Thyroid iodoproteins in vertebrates: ultracentrifugal pattern and iodination rate. Comp Biochem Physiol (1968) 0.85
Outpatient surgical procedures: which is the ideal teaching procedure for a resident surgeon? G Chir (2013) 0.84
Preferential sites of proteolytic cleavage of bovine, human and rat thyroglobulin. The use of limited proteolysis to detect solvent-exposed regions of the primary structure. Eur J Biochem (1993) 0.84
Fractionation techniques in a hydro-organic environment. I. Sulfolane as a solvent for hydrophobic proteins. Anal Biochem (1984) 0.84
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins. J Clin Endocrinol Metab (2000) 0.84